Boston Scientific (NYSE: BSX) has signed a definitive agreement to acquire Xlumena, Inc., a venture-backed medical device company that develops ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE